comparemela.com

Latest Breaking News On - Ilan vaknin - Page 1 : comparemela.com

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences

TEL AVIV, Israel, May 17, 2024 Chemomab Therapeutics Ltd. , a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today.

United statesHebrew universityBarbara lindheimIlan vakninAmnon peledInternational conventionGordon research conference on chemotactic cytokinesStrategic communicationsChemomab therapeutics ltdGordon research conferenceChemomab corporate developmentHadassah university hospitalChemotactic cytokinesAnnual congressEuropean associationResearch conference

Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare.

Barbara lindheimWadi morRaanan greenmanRifaat safadiAvi katavJohn lawlerHomer leviDouglas thorburnChris cirilloIrina kofflerMatthew frankelShelia sherlockTom snirChristopher bowlusIlan vakninMassimo pinzani

Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of.

United kingdomRebecca rossHilit leviIlan vakninIrina kofflerWadi morBarbara lindheimPrnewswire chemomab therapeutics ltdStrategic communicationsEuropean congressLifesci advisorsLeeds institute of rheumaticChemomab therapeutics ltdUniversity of leedsEuropean alliance of associationNew patient data further implicates

Chemomab Therapeutics to Present at Upcoming Scientific Conferences

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of.

United statesCrowne plaza woburnIrina kofflerIlan vakninBarbara lindheimWadi morFibrotic drug developmentLifesci advisorsChemomab therapeutics ltdProgressive biomarkers in clinical developmentWaltere washington convention centerStrategic communicationsPrnewswire chemomab therapeutics ltdUnion lateUnion world conference on lung healthConvention center

Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities

/PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of.

Israel generalDale pfostIrina kofflerIlan vakninBarbara lindheimBristol myers squibbLifesci advisorsCompugen ltdChemomab therapeutics ltdUniversity of tennesseeResearch developmentRhodes collegeStrategic communicationsPrnewswire chemomab therapeutics ltdHebrew university of jerusalemHealth sciences

vimarsana © 2020. All Rights Reserved.